pf-06473871
Nucleic acidexperimental
Clinical trial activity
3 trials · 1 clinical orgs · 0 marketing orgs
Phase 1
1
Phase 2
2
Phase 3
0
Phase 4
0
Earliest trial started Nov 1, 2012 (NCT01753791)
Timeline
Indications
Mechanism of action
- Connective tissue growth factorANTISENSE INHIBITOR
CCN2 antisense inhibitor
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Also known as
- pf-06473871
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT02205476 | Phase 2 | Dec 1, 2014 | Pfizer |
| NCT01730339 | Phase 2 | Dec 1, 2012 | Pfizer |
| NCT01753791 | Phase 1 | Nov 1, 2012 | Pfizer |
Showing 3 of 3 trials
Page 1 / 1
Organizations
Research & Development (1)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Pfizer | For profit | 3 | 3 | 2 | 2012 |
1 organizations
Page 1 / 1